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1. Introduction 
A coenzyme analogue with a reactive bromoacetyl 
group on the non-functional side of the molecule has 
been used previously to identify different cysteine 
residues at the active sites of alcohol dehydrogenases 
[ 1 ] . These cysteine residues are known to be ligands 
to the zinc atom at the catalytic centre [2]. Analogues 
with reactive substituents corresponding to other 
positions on the coenzyme molecule are potentially 
of interest for mapping the active sites of this and 
other dehydrogenases. In the present work, therefore, 
labelled residues in yeast and horse liver alcohol 
dehydrogenases have been identified after modifications 
with two other NAD analogues, 14C-labelled 
[3-(3-bromoacetylpyridinio)propyl] -adenosine 
pyrophosphate and [3-(4-bromoacetylpyridinio)-propyl] 
-adenosine pyrophosphate. 
Both analogues inactivated the yeast enzyme under 
conditions suggesting binding at the coenzyme-site 
[3,4], and led to covalent incorporation of 1 molecule 
of analogue per protein subunit [5,6]. The horse 
enzyme reacted similarly with the 4-bromoacetyl- 
pyridinio derivative but was not inactivated by the 
other analogue. Labelled residues in the proteins were 
identified by analysis of radioactive peptides after 
digestion with chymotrypsin. A limited variability in 
the labelling with different analogues was established, 
showing that the active sites of both alcohol dehydro- 
genases contain few reactive residues, in agreement with 
data from crystallographic studies of the horse enzyme 
[2] and results of structural comparisons [7]. 
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2. Materials and methods 
“C-carbonyl-labelled [3-(3-bromoacetylpyridinio)- 
propyl] -adenosine pyrophosphate and i4C-methylene- 
labelled [3-(4-bromoacetylpyridinio)-propyl]-adeno- 
sine pyrophosphate were synthesized [5,6] with 
specific radioactivities of 1.18 mCi/mmol and 2.1 
mCi/mmol, respectively. Alcohol dehydrogenase was 
prepared from yeast [8] and horse liver [9], the latter 
preparation containing mainly the EE isozyme. Both 
proteins were inhibited (5-50% of native activity, as 
indicated) with the coenzyme analogues, as previously 
described [5,6]. Reactions were stopped by additions 
of cysteine to a final concentration of 0.035 M. The 
incorporated label was stabilized by reduction with 
sodium borohydride [l] ‘in the presence of a few 
drops of octanol to reduce foaming. The hydride was 
added at 0°C in small portions to a final amount of 
10 mg per 100 mg protein; pH was maintained at pH 6 
with 1 N HCl. Optical properties and radioactivity of 
modified proteins were measured as previously 
described [l] . 
Labelled proteins (1 lo- 180 mg) were carboxy- 
methylated in 9 M urea, 0.1 mM iodoacetate at 4°C 
for 16 hr and reagents were removed by dialysis 
against distilled water. The freeze-dried protein samples 
were then suspended (5 mg/ml) in 1% ammonium 
bicarbonate, and digested at 37°C for 4 hr after each 
of two additions of TLCK-chymotrypsin in an amount 
of 1% of the total protein. This treatment resulted in 
soluble peptide mixtures which were freeze-dried and 
separated by exclusion chromatography on Sephadex 
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G-50 tine (Pharmacia, Uppsala, Sweden), 2.5 X 100 or 
5 X 100 cm, in 1% ammonium bicarbonate. Radio- 
active fractions were pooled and * 4 C-labelled peptides 
purified by high-voltage paper electrophoresis [l] . 
Structures of peptides and positions of labels were 
determined as previously described [ 11. 
3. Results 
3.1. Modification qfyeast alcohol dehydrogenase with 
/3-(3-bromoacet,vlpyridi~li~~)-propyl/e 
pyrophosphate 
Samples of the enzyme were treated with the 
analogue to almost complete inactivation (5% 
remaining enzymatic activity) or to about half this 
extent (49% activity) and chymotryptic peptides were 
fractionated as shown in figs. 1 and 2. Only one clear 
peak of radioactivity was obtained in each case. The 
corresponding material was pooled as indicated and 
shown by electrophoretic purification to correspond 
to only one “C-labelled peptide. It was acidic with an 
electrophoretic mobility [lo] at pH 6.5 of 0.25. 
Analysis for composition and sequence showed that 
the peptide was Ser-Gly-Val-X-Hi-Thr-Asp-Leu, 
From the structure of yeast alcohol dehydrogenase 
[ 1 l] X is known to correspond to a labelled derivative 
of Cys-43 in the protein. It was not stable during 
sequence analysis and the label was successively lost 
in solution (cf.). In the step removing the unknown 
cysteine derivative, however, excess label (about 
twice the background loss) was recovered. All other 
residues were recovered unmodified in full yield. Thus 
Cys-43 in yeast alcohol dehydrogenase is specifically 
labelled. Background labelling is highly limited at 
incomplete (fig.2) or even full (fig.1) inactivation. 
3.2. Modification qfyeast alcohol deh.vdrogenase with 
/ 3-(Cbromoacetylpyridi~lio)-propyil-adenosirle 
pJ)rophosphate 
The enzyme was labelled and analyzed in the same 
way as with the 3-bromoacetylpyridinio derivative. 
The elution pattern on exclusion chromatography of 
chymotryptic peptides of a partly inactivated sample 
(44% remaining enzymatic activity) is shown in fig.3. 
Completely inactivated enzyme gave still more radio- 
active peaks. 
Fractions were pooled as indicated in fig.3, and 
radioactive peptides purified and analyzed. The first 
peak was found to correspond to labelled Cys-43 in 
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Fig. 1. Exclusion chromatography of a chymotryptic digest of modified yeast alcohol dehydrogenase. Sephadex G-SO 
(2.5 X 100 cm) in 1% ammonium bicarbonate; 5% remaining enzymatic activity after modification with [3-(3-bromoacetyl- 
pyridinio)-propyl] -adenosine pyrophosphate. 
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Fig.2. Exclusion chromatography of a chymotryptic digest of modified yeast alcohol dehydrogenase. Sephadex G-50 fine 
(5 X 100 cm) in 1% ammonium bicarbonate; 49% remaining enzymatic activjty after modification with [3-(3-bromoacetyl- 
pyridinioj-propyl] -adenosine pyrophosphate. 
Volume (ml 1 
Fig.3. Exclusion chromatograpny of a chymotryptic digest of modified yeast alcohol dehydrogenase. Sephadex G-50 fine 
(5 X 100 cm) in 1% ammonium bicarbonate; 44% remaining enzymatic activity after modification with [3-(4-bromoacetyl- 
pyridinio)-propyl] -adenosine pyrophosphate. 
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a peptide with identical properties to that described 
above. The middle peak contained several weakly 
labelled peptides and therefore does not represent 
any specific modification. The last peak yielded one 
major radioactive compound. This was ninhydrin- 
negative and without detectable .amino acids. It is 
therefore likely to represent a non-peptide or degrada- 
tion product (cf. [l] ) of the instable coenzyme 
analogue. Thus, modification is more specific than 
indicated by fig.3; background labelling is represented 
mainly by the middle peak and the only modified 
residue identified is Cys-43. [3-(4-Bromoacetyl- 
pyridinio)-propyll-adenosine pyrophosphate therefore 
yields preferential label on the same cysteine residue 
as the 3-bromoacetylpyridinio derivative but with 
slightly less specificity. 
3.3. Modification of horse liver alcohol dehydrogenase 
with /3-(4-bromoacetyl-pyridinio)-propyl] 
-adenosine pyrophosphate 
Two samples of the enzyme were partly inactivated 
with the analogue (remaining enzymatic activities 
about 50%). Exclusion chromatography of chymotryptic 
peptides gave elution patterns with three peaks, but 
the relative peak heights were not reproducible. The 
last peak, eluted at 85% of the column’s total volume, 
corresponded mainly to one radioactive peptide, 
Be-Gly-X-Gly-Phe. From the structure of the 
protein [ 121, X is known to correspond to a labelled 
derivative of Cys-174. Remaining radioactivity in 
the eluate was divided among several weakly labelled 
fragments and the non-peptide material mentioned 
above. The weakly labelled peptides were recovered 
in bad yield. In those identified, label seemed to be 
associated with different cysteine residues. 
Thus, inactivation of horse liver alcohol dehydro- 
genase with [3-(4-bromoacetylpyridinio)-propyl] 
-adenosine pyrophosphate preferentially modifies 
Cys-174. Background labelling is variable but more 
extensive than with the yeast enzyme. This is 
probably related to the greater thiol content of the 
horse protein (fourteen [ 121 versus eight [ 131 
cysteine residues per subunit). 
4. Discussion 
4.1. Comparisons of results with different analogues 
Modifications of horse liver and yeast alcohol 
300 
dehydrogenases with reactive NAD analogues 
substituted on the non-functional side of the mole- 
cule [ 1 ] or on the functional, nicotinamide side 
(present work), show little variability. In all cases 
studied, Cys-43 in the yeast enzyme is labelled in a 
specific manner, and Cys-174 in the liver enzyme 
somewhat less specifically. The comparative reactivi 
ties of the analogues with the two proteins are also 
similar. [3-(3-Bromoacetyl-pyridinio)propyl] 
-adenosine pyrophosphate does not inactivate the 
horse enzyme and yields little background labelling 
with the yeast enzyme (figs.1 and 2); nicotinamide- 
S-bromoacetyl-4-methyl-imidazole dinucleotide is 
moderately specific with both enzymes [ I] ; and 
[3-(4-bromoacetylpyridinio)-propyl] -adenosine 
pyrophosphate yields detectable background labelling 
of both proteins even with incomplete reaction (fig.3). 
Labelled derivatives are unstable (cf. [ 1 ] ). No 
evidence for additional specific modifications, degraded 
before analysis was, however, obtained as judged from 
the distribution (figs.l-3) and quantitative analysis 
[ 1 ] of total radioactivity. A suggestion of selective 
labelling of histidine with one of the analogues [6] is 
therefore not supported but oxidation and acid 
hydrolysis was previously used 161. It is concluded 
that modified proteins should be treated mildly and 
preferably stabilized by reduction. 
4.2. Structural conclusions 
The two preferentially reactive cysteine residues 
occur in both of the homologous enzymes at similar 
numerical positions [ 1 ,l I]. Corresponding residues in 
either enzyme are close together in space, as shown by 
chemical modifications of both proteins [ 1,13- 161 
and crystallographic studies of the horse enzyme [2]. 
It is concluded that all coenzyme analogues studied 
affect similar regions at the active sites of both proteins. 
Minor differences between the two enzymes are also 
indicated, since alternative cysteine residues are 
consistently labelled. 
The small variation in modification with different 
NAD analogues demonstrates a limitation in the 
possibility of mapping particular residues, in spite of 
specific binding [ 1,3-61 of the analogues. Positions 
of substituents in analogues and proteins may not 
always be exactly correlated because of lack of 
sensitive residues correctly positioned for direct 
substitution. The limited variability therefore gives 
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strong evidence that both dehydrogenases contain 
few reactive residues close to either end of the bound 
coenzyme, apart from the centre containing the two 
cysteine residues. 
These results are in full agreement with crystallo- 
graphic studies of the horse enzyme, showing that its 
adenine and nicotinamide sites at the coenzyme- 
binding region are hydrophobic [2]. The labelling of 
Cys-174 in the horse enzyme by a nicotinamide- 
substituted analogue also eliminates a possible 
inconsistency in structural correlations by confirming 
that alkylation with the adenine-substituted analogue 
is caused by molecules anomalously bound [I] . This 
is compatible with the strictly hydrophobic nature of 
the adenine binding site of horse liver alcohol 
dehydrogenase (cf. [2] ). Furthermore, the labelling 
experiments show that the properties of the coenzyme 
binding region also apply to the yeast enzyme, 
confirming the similarities suggested from structural 
comparisons of particular residues in the two proteins 
171. 
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